Patients and their doctors have different perceptions about HIV and its treatment

May 22, 2006

According to results of a nation-wide study published in the latest issue of SAGE Publications' Journal of the International Association of Physicians in AIDS Care (JIAPAC), HIV positive patients and their doctors have very different views about the disease and how it's treated.

The study uncovered differences of opinion between patients and physicians about the initiation of treatment, the various goals of treatment, and even about whether or not the patient understands the doctors' explanations. These and other gaps in perception were revealed in the JIAPAC peer-reviewed article, "State of HIV Treatment: Results of IAPAC Surveys of HIV-Positive Patients and HIV-Treating Physicians in the United States."

The article explores the research findings about the attitudes of more than 500 HIV-positive patients and HIV-treating physicians regarding satisfaction with current treatment options, treatment side effects, patient-physician relationships, the importance of looking healthy, and other aspects related to HIV treatment.

"While the surveys highlighted many similar views between physicians and patients on issues such as treatment goals and satisfaction with currently available antiretroviral drugs," said José M. Zuniga, IAPAC President/CEO and the author of the JIAPAC article, "it is clear that more candid dialogue is needed to ensure a satisfactory treatment experience for people living with HIV/AIDS."
-end-
The IAPAC State of HIV Treatment Surveys was conducted in partnership with, and through funding provided by, Bristol-Myers Squibb, and administered by Richard Day Research.

A copy of the article can be accessed free of charge at http://jia.sagepub.com/cgi/reprint/5/2/51 for a limited time.

About SAGE:
SAGE Publications is a leading international publisher of journals, books, and electronic media for academic, educational, and professional markets. Since 1965, SAGE has helped inform and educate a global community of scholars, practitioners, researchers, and students spanning a wide range of subject areas including business, humanities, social sciences, and science, technology and medicine. SAGE Publications, a privately owned corporation, has principal offices in Thousand Oaks, California, London, United Kingdom, and New Delhi, India. www.sagepublications.com

About the International Association of Physicians in AIDS Care (IAPAC):
IAPAC aims to craft and implement global educational and advocacy strategies to improve the quality of care provided to all people living with HIV/AIDS. For more information about IAPAC, please visit www.iapac.org.

About Journal of the International Association of Physicians in AIDS Care (JIAPAC):
Journal of the International Association of Physicians in AIDS Care (JIAPAC), a quarterly, peer-reviewed journal, presents original research, research reviews, case studies, and clinical perspectives on the treatment of AIDS around the globe. A primary information resource for both developed and developing regions, JIAPAC explores the following topics and more in a variety of care settings: pathology, co-infections, clinical pharmacotherapeutics, diagnostic testing, epidemiology, health services, and cultural and behavioral influences on AIDS and its treatment. http://jiapac.sagepub.com

SAGE

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.